Febrile Illness
0
Pipeline Programs
5
Companies
3
Clinical Trials
1 recruiting
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
5 companies ranked by most advanced pipeline stage
Ahead TherapeuticsSpain - Barcelona
2 programsIncidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast AsiaN/A1 trial
Rural Health Surveillance Program - Febrile IllnessN/A
Active Trials
BraccoItaly - Milan
1 programIncidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast AsiaN/A
Allergy TherapeuticsUK - West Sussex
1 programRapid Diagnostic Tests (RDTs) for Malaria in Kampala, UgandaN/A1 trial
Active Trials
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Baxter InternationalConnex CVSM with Timmy3 module
Ahead TherapeuticsIncidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast Asia
Allergy TherapeuticsRapid Diagnostic Tests (RDTs) for Malaria in Kampala, Uganda
Clinical Trials (3)
Total enrollment: 100,973 patients across 3 trials
Timmy3 Module Clinical Accuracy ISO 80601-2-56:2017 + A1 2018
Start: Feb 2024Est. completion: Mar 2025373 patients
N/ACompleted
NCT04478578Ahead TherapeuticsIncidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast Asia
Incidences, Causes, and Outcomes of Febrile Illness in Rural South and Southeast Asia
Start: Aug 2021Est. completion: Dec 2024100,000 patients
N/ARecruiting
Rapid Diagnostic Tests (RDTs) for Malaria in Kampala, Uganda
Start: Oct 2005Est. completion: May 2006600 patients
N/ACompleted
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
1 actively recruiting trials targeting 100,973 patients
5 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.